{
    "2018-07-24": [
        [
            {
                "time": "2018-07-31",
                "original_text": "Novartis’s Key Developments in July",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Key Developments",
                        "July"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-02",
                "original_text": "Novartis’s Q2 2018 Earnings: Sandoz",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Q2 2018 Earnings",
                        "Sandoz"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        " generics"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}